WS Audiology A/S
WS Audiology is a global leader in the hearing aid industry that helps millions of people regain and enjoy their hearing by designing and manufacturing innovative hearing devices and solutions.
Formed in 2019, through the merger of Sivantos and Widex, WS Audiology combines over 140 years’ of experience in pioneering the use of technology to help people with hearing loss hear the sounds that make life wonderful.
WS Audiology employs 12,500+ people across 45 markets and actively markets its differentiated brands and care and diagnostic solutions in over 130 markets. The company has three R&D hubs in Denmark, Germany and Singapore, supported by a global R&D organization, and seven main production sites in Denmark, Singapore, China, Mexico, Poland, USA and the Philippines.
In the financial year 2022/2023, WS Audiology delivered revenue growth of 5% to DKK 18,389 million driven by progress in all regions. Reported EBITDA increased by 14% to DKK 3,581 million.
WS Audiology is privately owned by the Tøpholm and Westermann families and the Lundbeck Foundation (51% - through the joint ownership of CN8 A/S) and EQT (49%). The Tøpholm and Westermann families control the company CN8 A/S, where the Lundbeck Foundation is a minority investor.